Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2007HepatologyOpen Access

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus

View Full Paper
Ask AI
Bookmark
Share

Authors

John G. McHutchison
John G. McHutchisonHuman Genome Sciences (United States)BBBruce R. BaconUniversity of Arkansas at Little RockSGStuart C. GordonHenry Ford Health System

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McHutchison et al. (2007) studied this question.

synapsesocial.com/papers/6a8331c6292d2964071f307fhttps://doi.org/10.1002/hep.21773
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data2000 · 508 citations
  2. 2The natural history of chronic hepatitis C infection1996 · 59 citations
  3. 3The Third Gas: H2S Regulates Perfusion Pressure in Both the Isolated and Perfused Normal Rat Liver and in Cirrhosis *2005 · 560 citations